BUDESONIDE | N213976 | TAKEDA PHARMACEUTICALS USA INC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
TAKEDA PHARMACEUTICALS U.S.A., INC. et al v. LUPIN, LTD. et al 2 patentsANDA 220382budesonide | D.N.J. | 2025-07-01 | Active | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$3.22
per ml
Lowest NADAC/Unit
$3.22
per ml
Brand NDCs
1
Generic NDCs
0
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 64764010560EOHILIA 2 MG/10 ML PACKET | $3.22 | ML | Brand | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|---|---|---|---|---|---|
| 8324192 | Aug 3, 2029 | — | — | — | — | |
| 8497258 | Nov 9, 2026 | — | — | — | — | |
| 8679545 | Nov 9, 2026 | — | — | Yes | — | — |
| 8975243 | Nov 9, 2026 | — | — | — | — | |
| 9050368 | Aug 1, 2029 | — | — | Yes | — | — |
| 9119863 | Nov 9, 2026 | — | — | — | — | |
| 10293052 | Nov 22, 2028 | — | — | Yes | — | — |
| 11197822 | Nov 9, 2026 | — | — | Yes | — | — |
| 11260064 | Jan 10, 2039 | — | — | Yes | — | — |
| 11357859 | Nov 12, 2028 | — | — | — | — | |
| 11413296 | Nov 9, 2026 | — | — | Yes | — | — |
| 11564934 | Jan 10, 2039 | — | — | — | — |
| Code | Date | Status |
|---|---|---|
| NP | Feb 9, 2027 | < 1 year |
| ODE-466 | Feb 9, 2031 | Active |